Wordt geladen...
Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab for Follicular Lymphoma
Bendamustine (B) with rituximab (R) is a standard frontline treatment for medically fit follicular lymphoma (FL) patients. The safety and efficacy of maintenance rituximab (MR) after BR induction has not been formally compared to observation for FL, resulting in disparate practice patterns. Prospect...
Bewaard in:
| Gepubliceerd in: | Br J Haematol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486816/ https://ncbi.nlm.nih.gov/pubmed/30575016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15720 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|